RQSI’s PDL BioPharma, Inc. PDLI Stock Holding History

RQSI’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-50,270	Closed	-$354K	–	254
2015 Q1	$354K	Sell	50,270 -2,183	-4%	-$15.8K	0.19%	169
2014 Q4	$404K	Buy	+52,453	New	+$415K	0.38%	167

Other funds holding PDLI

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RQSI's PDLI Position: Q2 2015 in Review

RQSI sold out of PDL BioPharma, Inc. (PDLI) in Q2 2015, closing a stake of 50,270 shares — an estimated $354K sold.

RQSI first reported a position in PDLI in Q4 2014 and held it in 2 quarters. The position peaked at $404K in Q4 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q2 2015.

RQSI reported no remaining PDL BioPharma, Inc. position as of Q2 2015 after selling out during the quarter.
RQSI sold 50,270 PDL BioPharma, Inc. shares in Q2 2015, an estimated $354K.
RQSI first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 2 quarters.
RQSI's PDL BioPharma, Inc. position peaked at $404K in Q4 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2015.

Based on RQSI's 13F filing for Q2 2015, filed 27 Jul 2015.